Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults

Summary

The purpose of this study is to evaluate the safety, reactogenicity and immunogenicity of a booster dose of pneumococcal vaccines (GSK 2189242A) in young adults. This protocol posting deals with objectives \& outcome measures of the booster phase. The objectives \& outcome measures of the primary phase are presented in a separate protocol posting (NCT 00707798)

Timeline

Start

2009-05-18

Primary completion

2009-08-05

Completion

2009-08-05

Drugs

Indications